Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Find out which option tends to yield steadier income—index funds or bonds—and how to blend them for reliability and growth.
24,934 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
When two tech giants renew a crucial chip deal, markets react fast. Discover how the Broadcom collaboration could sha...
AI megatrends are reshaping portfolios, and Robinhood users are flocking to chipmakers. This guide highlights the thr...
Samara unveils Locale by Samara, its first single-family model in California, aiming to ease housing shortages by bui...
Cybersecurity shares jumped after inflation data cooled, lifting risk sentiment. CrowdStrike climbs 11% and Palo Alto...
IBM's latest profit warning sheds light on the strength and limits of AI demand, cloud growth, and enterprise spendin...
Beaten-down brands aren’t a bet on luck—they’re a test of resilience. This piece explores two stocks down right hold ...
AI-driven data centers are keeping DRAM prices high as demand for high-bandwidth memory tightens supply. Market obser...
Nebius soars 16% after NVIDIA discloses a 9.3% stake, prompting a rally in AI cloud peers like CoreWeave and Oracle a...
A high-profile insider move raises questions about strategy and sentiment. This article breaks down the Paychex share...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
RE/MAX elevates Chris Lim to president while bringing in two new global sales leaders to drive growth across its affi...